0/6
0/8
0/6
Welcome to the NPLB Biotech Social Contract Game! You are a healthcare policymaker. Prove that biotech innovation investment and affordability for patients can live in harmony by sorting each policy from the docket into its primary goal. Choose wisely!
Policies that undermine the biotech social contract and why they were shredded:
You left your patients (and voters) behind. Try again!
Without the right balance between biotech investment and affordability for patients, the biotech social
contract breaks down.
You proved that biotech innovation investment and patient affordability can coexist harmoniously. True policy balances access to innovative treatments with long-term generic pipelines, a finite reward for innovators, followed by inexpensive generics for society, forever.
Learn More at No Patient Left Behind